AU2002233994A1 - Secreted proteins - Google Patents
Secreted proteinsInfo
- Publication number
- AU2002233994A1 AU2002233994A1 AU2002233994A AU3399402A AU2002233994A1 AU 2002233994 A1 AU2002233994 A1 AU 2002233994A1 AU 2002233994 A AU2002233994 A AU 2002233994A AU 3399402 A AU3399402 A AU 3399402A AU 2002233994 A1 AU2002233994 A1 AU 2002233994A1
- Authority
- AU
- Australia
- Prior art keywords
- secreted proteins
- secreted
- proteins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
- H04L1/00—Arrangements for detecting or preventing errors in the information received
- H04L1/12—Arrangements for detecting or preventing errors in the information received by using return channel
- H04L1/16—Arrangements for detecting or preventing errors in the information received by using return channel in which the return channel carries supervisory signals, e.g. repetition request signals
- H04L1/1607—Details of the supervisory signal
- H04L1/1657—Implicit acknowledgement of correct or incorrect reception, e.g. with a moving window
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24750500P | 2000-11-08 | 2000-11-08 | |
US60/247,505 | 2000-11-08 | ||
US24964200P | 2000-11-16 | 2000-11-16 | |
US24982400P | 2000-11-16 | 2000-11-16 | |
US60/249,642 | 2000-11-16 | ||
US60/249,824 | 2000-11-16 | ||
US25282400P | 2000-11-21 | 2000-11-21 | |
US60/252,824 | 2000-11-21 | ||
US25430500P | 2000-12-08 | 2000-12-08 | |
US60/254,305 | 2000-12-08 | ||
US25644800P | 2000-12-18 | 2000-12-18 | |
US60/256,448 | 2000-12-18 | ||
PCT/US2001/047420 WO2002038602A2 (en) | 2000-11-08 | 2001-11-08 | Secreted proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002233994A1 true AU2002233994A1 (en) | 2002-05-21 |
Family
ID=27559348
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002233994A Abandoned AU2002233994A1 (en) | 2000-11-08 | 2001-11-08 | Secreted proteins |
Country Status (5)
Country | Link |
---|---|
US (1) | US20040082508A1 (en) |
EP (1) | EP1341812A2 (en) |
AU (1) | AU2002233994A1 (en) |
CA (1) | CA2428140A1 (en) |
WO (1) | WO2002038602A2 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6974684B2 (en) * | 2001-08-08 | 2005-12-13 | Curagen Corporation | Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
EP1308512B1 (en) * | 2000-08-10 | 2007-05-23 | Takeda Pharmaceutical Company Limited | Novel proteins and dnas thereof |
CA2427798A1 (en) * | 2000-11-01 | 2003-01-03 | Zymogenetics, Inc. | Testis protein, zsig86 |
EP1369479A4 (en) * | 2001-02-15 | 2004-12-08 | Mochida Pharm Co Ltd | Novel cell adhesion molecule specific to activated leukocyte |
WO2005003161A2 (en) * | 2003-06-30 | 2005-01-13 | Genova Ltd. | Human secreted proteins |
PT1752471E (en) | 2005-01-05 | 2009-02-26 | F Star Biotech Forsch & Entw | SYNTHETIC IMMUNOGLOBULIN DOMAINS WITH CONNECTION PROPERTIES CONSTRUCTED IN MOLECULA REGIONS DIFFERENT FROM COMPLEMENTARY DETERMINING REGIONS |
WO2006102072A2 (en) * | 2005-03-23 | 2006-09-28 | The Trustees Of The University Of Pennsylvania | Use of a pa131 polypeptide in treatment of atherosclerosis |
EP2438962A3 (en) | 2006-02-13 | 2012-07-18 | Alethia Biotherapeutics Inc. | Polynucleotides and polypeptide sequences involved in the process of bone remodeling |
US8168181B2 (en) | 2006-02-13 | 2012-05-01 | Alethia Biotherapeutics, Inc. | Methods of impairing osteoclast differentiation using antibodies that bind siglec-15 |
AT503889B1 (en) | 2006-07-05 | 2011-12-15 | Star Biotechnologische Forschungs Und Entwicklungsges M B H F | MULTIVALENT IMMUNE LOBULINE |
PL3241842T3 (en) | 2007-06-26 | 2024-06-10 | F-Star Therapeutics Limited | Display of binding agents |
CA2875310A1 (en) | 2007-10-11 | 2009-04-16 | Daiichi Sankyo Company, Limited | Antibody targeting osteoclast-related protein siglec-15 |
EP2113255A1 (en) | 2008-05-02 | 2009-11-04 | f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. | Cytotoxic immunoglobulin |
MY152033A (en) | 2009-04-09 | 2014-08-15 | Daiichi Sankyo Co Ltd | Anti-siglec-15 antibody |
RU2013119983A (en) | 2010-10-05 | 2014-11-20 | Дайити Санкио Компани, Лимитед | ANTIBODY AIMED AT SIGLEK-15 PROTEIN ASSOCIATED WITH OSTEOCLASTS |
BR112014024269A8 (en) | 2012-03-30 | 2017-07-25 | Daiichi Sankyo Co Ltd | ANTIBODY OR AN ANTIGEN-BINDING FRAGMENT OF ANTIBODY, ANTIGEN-BINDING FRAGMENT OF ANTIBODY, PHARMACEUTICAL COMPOSITION, USE OF AN ANTIBODY OR AN ANTIGEN-BINDING FRAGMENT, USE OF A COMPOSITION, VECTOR, TRANSFORMED HOST CELL, AND METHOD FOR PRODUCING AN ANTIBODY |
EA201590247A1 (en) | 2012-07-19 | 2015-10-30 | Алетиа Байотерапьютикс Инк. | ANTIBODIES TO SIGLEC-15 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1080106A1 (en) * | 1998-05-18 | 2001-03-07 | Genetics Institute, Inc. | Secreted proteins and polynucleotides encoding them |
EP1112285A1 (en) * | 1998-08-10 | 2001-07-04 | Genetics Institute, Inc. | Human chordin-related proteins and polynucleotides encoding them |
JP2002522062A (en) * | 1998-08-14 | 2002-07-23 | ジェネティックス・インスチチュート・インコーポレーテッド | Secreted proteins and polynucleotides encoding them |
GB0012186D0 (en) * | 2000-05-20 | 2000-07-12 | Univ Leeds | Treatment of cancer and neurological diseases |
-
2001
- 2001-11-08 WO PCT/US2001/047420 patent/WO2002038602A2/en not_active Application Discontinuation
- 2001-11-08 US US10/416,314 patent/US20040082508A1/en not_active Abandoned
- 2001-11-08 EP EP01985000A patent/EP1341812A2/en not_active Withdrawn
- 2001-11-08 AU AU2002233994A patent/AU2002233994A1/en not_active Abandoned
- 2001-11-08 CA CA002428140A patent/CA2428140A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2428140A1 (en) | 2002-05-16 |
WO2002038602A2 (en) | 2002-05-16 |
EP1341812A2 (en) | 2003-09-10 |
WO2002038602A3 (en) | 2003-06-26 |
US20040082508A1 (en) | 2004-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001271683A1 (en) | Novel secreted proteins | |
AU2001280471A1 (en) | Novel secreted proteins and their uses | |
AU2002233994A1 (en) | Secreted proteins | |
AU2002361452A1 (en) | Secreted proteins | |
AU2001270045A1 (en) | Secreted proteins | |
AU2002353227A1 (en) | Secreted proteins | |
AU2001227833A1 (en) | 71 human secreted proteins | |
AU2002232596A1 (en) | Secreted human proteins | |
AU2002342010A1 (en) | Secreted proteins | |
AU2001255320A1 (en) | Secreted proteins | |
AU2002354803A1 (en) | Secreted proteins | |
AU2002211220A1 (en) | Secreted proteins and their uses | |
AU2002252700A1 (en) | Secreted proteins | |
AU2002255733A1 (en) | Secreted proteins | |
AU2001294719A1 (en) | Secreted human proteins | |
AU2001290551A1 (en) | Secreted proteins and their uses | |
AU2001229366A1 (en) | Secreted proteins | |
AU2002236440A1 (en) | Novel secreted proteins and their uses | |
AU2002258657A1 (en) | Secreted proteins | |
AU2002327533A1 (en) | Secreted proteins | |
AU2002239747A1 (en) | Cystoskeleton-associated proteins | |
AU2001244863A1 (en) | Apoptin-associating protein | |
AU2001229507A1 (en) | 21 human secreted proteins | |
AU2390800A (en) | Secreted proteins | |
AU2001229503A1 (en) | 17 human secreted proteins |